or
forgot password

    • cancer clinical trials in midland, TX

    • Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    Allison Cancer Center, Texas Oncology, P.A.
    Midland, Texas 79701
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Allison Cancer Center
    Midland, Texas 79701
    Lymphoma, T-Cell, Peripheral
    PhII ICb With/Without Erbitux in MBC Pts
    Allison Cancer Center
    Midland, Texas 79701
    Metastatic Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Allison Cancer Center
    Midland, Texas 79701
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Allison Cancer Center
    Midland, Texas 79701
    Breast Cancer
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    Allison Cancer Center
    Midland, Texas 79701
    Metastatic Gastric or GEJ Cancer
    Pre-op Rectal ChemoRad +/- Cetuximab
    Allison Cancer Center
    Midland, Texas 79701
    Rectal Cancer
    Phase II Sunitinib Prog Met AIPC
    Allison Cancer Center
    Midland, Texas 79701
    Metastatic Prostate Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Allison Cancer Center
    Midland, Texas 79701
    Androgen-independent Prostate Cancer
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Allison Cancer Center
    Midland, Texas 79701
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Texas Oncology, Allison Cancer Center
    Midland, Texas 79701
    Melanoma
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Texas Oncology, PA, Allison Cancer Center
    Midland, Texas 79701
    Urothelial Cancer
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location # 28
    Midland, Texas 79701
    Metastatic Breast Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Texas Oncology-Midland Allison Cancer Center
    Midland, Texas 79701
    Metastatic Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Allison Cancer Center
    Midland, Texas 79701
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Allison Cancer Center
    Midland, Texas 79701
    Multiple Myeloma
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Texas Oncology-Midland Allison Cancer Center
    Midland, Texas 79701
    Chronic Myeloid Leukemia
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Texas Oncology-Midland Allison Cancer Center
    Midland, Texas 79701
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    US Oncology - Texas Oncology Midland, Site #173
    Midland, Texas 79701
    Chronic Myeloid Leukemia
    HORIZON-PFT: Pivotal Fracture Trial
    Diabetes Regional Research Center
    Midland, Texas 79705
    Osteoporosis
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Allison Cancer Center
    Midland, Texas 79701
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Allison Cancer Center
    Midland, Texas 79701
    Carcinoma, Non-Small-Cell Lung
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Texas Oncology, PA / Allison Cancer Center
    Midland, Texas 79701-5946
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Alison Cancer Center
    Midland, Texas 79701
    Metastatic Breast Cancer
    A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
    Texas Oncology - Allison Cancer Center
    Midland, Texas 79701
    Non-Small Cell Lung Cancer
    Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
    Texas Oncology - Allison Cancer Center
    Midland, Texas 79701
    Non-Small Cell Lung Cancer
    Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
    Allison Cancer Center
    Midland, Texas 79701
    Anemia, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small-Cell Lung, Bladder Cancer, Cancer of Head and Neck, Uterine Cervical Cancer